Executive Officer and General Manager at Institute of Health Sciences, Kirin Holdings Co., Ltd. My major role is to link scientific novel findings to business schemes based on the credibility of science. Kirin's vision is clear a path for social contribution by distribution of products that maintain healthy individual's life. My recent topic is that we have achieved health claims of immunity for the first time in Japanese history. This is based on my research activity and negotiation with government about Lactococcus Plasma.During on long basic research history, I have discovered a number of scientific findings and new materials that are related with human health care. Among them we are moving on with Lactococcus Plasma (iMMUSE) and Lactobacillus KW (EYEMUSE) that maintain health via stimulation of immnity. Especially given rising interest against viral infection, we have received a number of interests regarging with Lactococcus Plasma (iMMUSE) globally. Lactococcus Plasma is the only lactic acid bacteria that specifically stimulate anti-viral immunity by activating pDC. We have numerous scientific evidences consisted with 32 academic publications including 17 human clinical trials and Lactococcus Plasma is endorsed by various medical societies. As a consequence, Lactococcus Plasma became the first ingredient which can claim of immune function in Japanese history. Now, still there are lots of ongoing scientific projects to be announced in the near future. I am always open to such fruitful communications, so please feel free to contact me.